As in other RTK family proteins, aberrant expression of MerTK in various malignant tumors, such as melanoma [12, 13], gastric cancer [14], leukemia [15–17], and lung cancer [18], plays a pivotal role in the process of oncogenesis. Here, MERTK is linked to leukemia.